<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153178">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02090790</url>
  </required_header>
  <id_info>
    <org_study_id>2013/400</org_study_id>
    <nct_id>NCT02090790</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block</brief_title>
  <official_title>The Compare the Effect of Peroperative Intravenous Single Dose Dexamethasone and the Addition of Dexamethasone to Femoral Nerve Block on Postoperative Analgesic Consumption Anf Patient Comfort in Unilateral Total Knee Arthroplasty Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      the aim of this study was to investigate  compare the effect of peroperative intravenous
      single dose dexamethasone and the addition of dexamethasone to femoral nerve block on
      postoperative analgesic consumption and patient comfort in unilateral total knee
      arthroplasty patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty leads to severe postoperative pain.  for postoperative pain control
      after total knee arthroplasty oral -intramuscular opioids ,patient controlled analgesia
      intravenous or epidural opioids,  single -continuous femoral nerve block involving
      techniques are used.

      Dexamethasone is a glucocorticoid of high potency and frequently used
      perioperative.Dexamethasone to the local anaesthetic solution administered trough in femoral
      nerve blocks significantly prolonged the analgesic effect of the local anaesthetics used on
      this blocks.If the analgesic efficacy of systemic treatment with dexamethasone is similar
      with the use of perineural wich is the safest way should be preferred for systemic use.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>visual analog scale</measure>
    <time_frame>postoperative 2 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>postoperative 2 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>morphine consumption (patient controlled analgesia procedure)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>iv dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>perioperative 2ml 8 mg ıv dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>femoral dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>femoral block was performed postoperative 30 ml 0,5 % bupivacaine added 2 ml 8 mg dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serum physiologic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>iv dexamethasone</intervention_name>
    <description>2 ml 8 mg iv dexamethasone</description>
    <arm_group_label>iv dexamethasone</arm_group_label>
    <other_name>decort</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>femoral dexamethasone</intervention_name>
    <description>2ml 8mg dexamethasone administration added 30 ml 0,5 % bupivacain</description>
    <arm_group_label>femoral dexamethasone</arm_group_label>
    <other_name>dekort</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>serum physiologic</intervention_name>
    <description>2 ml iv serum physiologic</description>
    <arm_group_label>serum physiologic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between 18-65 age

          -  knee arthroplasty

          -  no known allergies to drugs

          -  ASA 1-2 patients

        Exclusion Criteria:

          -  history of diabetes

          -  history of chronic pain treatment

          -  pregnancy

          -  severe bronchopulmonary disease

          -  systemic opioid and steroid use
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmet öner, recident</last_name>
    <role>Principal Investigator</role>
    <affiliation>erciyes univercity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>gülen güler, prof</last_name>
    <role>Study Director</role>
    <affiliation>erciyes univercity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ahmet öner, resident</last_name>
    <phone>+9055059504112</phone>
    <email>dr_ahmetoner@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>gülen güler, prof</last_name>
    <phone>+905327922484</phone>
    <email>gulen@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes Univercity Hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmet öner, resident</last_name>
      <phone>+905059504112</phone>
      <email>dr_ahmetoner@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>gülen güler, prof</last_name>
      <phone>+905327922484</phone>
      <email>gulen@erciyes.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 20, 2014</lastchanged_date>
  <firstreceived_date>March 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>ahmet öner</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>dexamethasone</keyword>
  <keyword>femoral block</keyword>
  <keyword>total knee arthroplasty</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
